| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Internal Medicine (B.C., G.L., V.R., R.G., L.S.) and Endocrinology (P.M., A.C., G.L.), University Federico II, 80131 Naples, Italy
Address correspondence and requests for reprints to: Luigi Saccà, M.D., Department of Internal Medicine, University Federico II, Via Pansini 5, 80131 Naples, Italy. E-mail: sacca{at}unina.it
Muscle sympathetic nerve activity was measured in nine acromegalic
patients (age, 35 ± 4 yr; body mass index, 28 ± 2
kg/m2) and eight healthy subjects (age, 32 ± 3 yr;
body mass index, 25 ± 2 kg/m2) by combining the
forearm arterial-venous difference technique with the tracer method
[infusion of tritiated norepinephrine (NE)]. Muscle NE release was
quantified both at rest and during physiological hyperinsulinemia while
maintaining euglycemia (
90 mg/dL) by means of the euglycemic
clamp.
Arterial plasma NE was similar in the two groups at rest (197 ± 28 and 200 ± 27 pg/mL-1) and slightly increased during insulin infusion. Forearm NE release was 2.33 ± 0.55 ng·liter-1·min-1 in healthy subjects and 2.67 ± 0.61 ng·liter-1·min-1 in acromegalic subjects in the basal state and increased to a similar extent during insulin infusion in both groups (3.13 ± 0.71 and 3.32 ± 0.75 ng·L-1· min-1, P < 0.05 vs. basal), indicating a normal stimulatory effect of insulin on muscle sympathetic activity. In contrast, insulin-stimulated forearm glucose uptake was markedly lower in acromegalic patients (2.3 ± 0.4 mg·L-1·min-1) than in control subjects (7.9 ± 1.3 mg·L-1·min-1, P < 0.001), indicating the presence of severe insulin resistance involving glucose metabolism.
Our data demonstrate that patients with long-term acromegaly have normal sympathetic activity in the skeletal muscle in the basal, postabsorptive state and normal increments in NE spillover in response to the sympatho-excitatory effect of insulin. Thus, the presence of severe insulin resistance in acromegaly is not accounted for by adrenergic mechanisms.
This article has been cited by other articles:
![]() |
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults Endocr. Rev., May 1, 2006; 27(3): 287 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colao, D. Ferone, P. Marzullo, and G. Lombardi Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management Endocr. Rev., February 1, 2004; 25(1): 102 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cittadini, A. Berggren, S. Longobardi, C. Ehrnborg, R. Napoli, T. Rosen, S. Fazio, K. Caidahl, B.-A. Bengtsson, and L. Sacca Supraphysiological Doses of GH Induce Rapid Changes in Cardiac Morphology and Function J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1654 - 1659. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |